2018

1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

   American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522